Equivalence of Type 2 Diabetes Prevalence Estimates: Comparative Study of Similar Phenotyping Algorithms Using Electronic Health Record Data
JMIR Public Health and Surveillance · 2025
DOI: 10.2196/79653 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JMIR Public Health and Surveillance, 2025. Verfasst von Muchiri E Wandai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Regenstrief Institute, 1101 West 10th Street, Indianapolis, IN, 46202, United States, 1 317-274-9000. Hauptthemen laut MEDLINE: Phenotype, Electronic Health Records, Algorithms, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCCDPHP CDC HHS, JG CDC HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Timely surveillance of diabetes mellitus remains a challenge for public health agencies. In this study, researchers compared type 2 diabetes (T2D) prevalence estimates using electronic health record (EHR) data and computable phenotypes (CPs) as defined and applied by 2 independent networks. One network, Diabetes in Children, Adolescents, and Young Adults, was a research consortium, and the other, the Multi-State EHR-Based Network for Disease Surveillance, is a practice-based public health surveillance network.
Objective
This study sought to determine the equivalence of T2D prevalence estimates generated by 2 distinct, yet conceptually related, CPs using EHR data.
Methods
Each network used diagnostic, laboratory, and medication data for young adults (aged 18-44 years) extracted from the Indiana Network for Patient Care (INPC) to independently calculate prevalence of T2D using distinct CPs for the year 2022. The INPC is a statewide health information exchange that receives EHR data from multiple health care systems and supports public health use cases such as surveillance. The two one-sided tests method for independence with a predefined margin of –2.5 to +2.5 percentage points was used to compare the estimated prevalence as previously derived from the Multi-State EHR-Based Network for Disease Surveillance and Diabetes in Children, Adolescents, and Young Adults networks. The two one-sided tests for equivalence show that any observed difference between 2 estimates is small and practically insignificant. Results at the overall level, and stratified by sex, age, and race or ethnicity, were examined.
Results
Overall prevalence estimates for 2022 were 4.1% for CP 1 and 2.4% for CP 2. Although prevalence estimates for CP 1 were consistently higher than those for CP 2, absolute differences were generally less than 2.5 percentage points, which did not result in a statistically significant ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Regenstrief Institute, 1101 West 10th Street, Indianapolis, IN, 46202, United States, 1 317-274-9000.
- Richard M. Fairbanks School of Public Health (FSPH), Indiana University, Indianapolis, IN, United States.
ORCID-Profile: Muchiri E Wandai, Katie S Allen, Ashley Wiensch, John Price, Brian E Dixon
Förderung
- NIDDK NIH HHS
- NCCDPHP CDC HHS
- JG CDC HHS
Zitieren
APA
Wandai, M. E., Allen, K. S., Wiensch, A., Price, J., & Dixon, B. E. (2025). Equivalence of Type 2 Diabetes Prevalence Estimates: Comparative Study of Similar Phenotyping Algorithms Using Electronic Health Record Data. JMIR Public Health and Surveillance. https://doi.org/10.2196/79653
Vancouver
Wandai ME, Allen KS, Wiensch A, Price J, Dixon BE. Equivalence of Type 2 Diabetes Prevalence Estimates: Comparative Study of Similar Phenotyping Algorithms Using Electronic Health Record Data. JMIR Public Health and Surveillance. 2025. doi:10.2196/79653
BibTeX
@article{Wandai2025,
author = {Wandai, Muchiri E and Allen, Katie S and Wiensch, Ashley and Price, John and Dixon, Brian E},
title = {Equivalence of Type 2 Diabetes Prevalence Estimates: Comparative Study of Similar Phenotyping Algorithms Using Electronic Health Record Data},
journal = {JMIR Public Health and Surveillance},
year = {2025},
doi = {10.2196/79653}
}
EUVIMED